Physician Group Acquisition Financing and Partner Buy-Ins: Capital for Multi-Doctor Practices

Independent and physician-owned medical groups have become some of the most active acquirers in U.S. healthcare. Multi-doctor practices buying neighboring single-physician offices, specialty groups consolidating regional footprints, and senior partners transitioning ownership to incoming associates have driven a wave of mid-market healthcare M&A that shows no signs of slowing. Physician group acquisition financing — the layered capital stack that funds these transactions — has matured alongside the deal flow. The American Medical Association's Physician Practice Benchmark Survey tracks the long-term shift in practice size and ownership — practices with 11 or more physicians now represent a meaningful share of physician employment, and most growth in that segment has come through acquisition rather than organic hiring.

The financing structures that support those transactions are well-established but specific to healthcare. Physician group acquisition financing typically combines a senior credit facility, subordinated or mezzanine capital, partner buy-in notes, and seller financing into a single closing package. This guide walks through how each piece fits together for multi-doctor practices completing acquisitions, ownership transitions, and partner buy-ins in the $2M to $25M+ transaction range.

KEY TAKEAWAYS

Multi-doctor practice acquisitions are typically financed with a combination of senior debt, subordinated capital, partner buy-in notes, and seller paper — not a single product.
Mature physician groups are highly financeable because cash flow is predictable, receivables are concentrated with creditworthy payors, and the business has tangible going-concern value.
Partner buy-ins are often financed separately from the underlying group's senior debt, using a personal or practice-guaranteed term loan structured around the buy-in timeline.
Subordinated debt fills the gap between what a senior bank lender will provide and total transaction value — typically 1.0x to 2.0x EBITDA of additional capacity.
Noble Funding provides financing for physician group acquisitions and partner buy-ins in the $1M to $25M+ range — call 1-800-916-3196 for a confidential consultation.

WHY PHYSICIAN GROUPS ARE STRONG ACQUISITION-FINANCING CANDIDATES

Lenders underwrite physician groups differently than most professional service businesses. The combination of predictable revenue, creditworthy payors, and clear going-concern value makes mature multi-doctor practices unusually financeable.

The attributes that drive credit appetite:

Predictable patient volume and revenue. Established groups with stable patient panels show low revenue volatility compared with most small businesses.
Creditworthy payor mix. Commercial insurers, Medicare, Medicaid managed care plans, and self-pay/copay collections produce a diversified, high-quality receivables base.
Documented historical cash flow. Multi-year tax returns, financial statements, and practice management reports give lenders strong underwriting data.
Tangible going-concern value. Patient panels, payor contracts, location goodwill, and physician productivity translate directly into enterprise value.
Manageable working capital cycles. Most groups collect within 30 to 60 days of service, with predictable A/R aging.

For multi-doctor groups in steady-state operation, all of those characteristics translate into senior debt capacity in the range of 3.0x to 4.0x adjusted EBITDA, depending on specialty, payor mix, and concentration with any single physician.

THE PHYSICIAN GROUP ACQUISITION FINANCING CAPITAL STACK

A representative $10M acquisition of a smaller practice by an established mid-sized group might be capitalized as follows:

Senior debt — $5M to $6M. Funded through a commercial mortgage (if owned real estate is involved), a senior term loan secured by the practice and its assets, or a working capital facility structured around accounts receivable.
Subordinated debt — $2M to $3M. Subordinated debt financing sits behind the senior lender and provides the "stretch" capital that senior debt alone will not support. Typically structured as a 5 to 7-year term with interest-only periods.
Seller financing — $1M to $2M. A promissory note to the selling physician(s), often structured to align with non-compete and transition-of-care obligations.
Buyer equity / partner contributions — $1M to $2M. Cash from the acquiring practice's partners, often financed via individual partner buy-in loans.

The exact mix shifts with the deal — single-asset acquisitions look different from multi-location roll-ups — but the four-layer pattern is consistent across most mid-market physician group transactions.

PARTNER BUY-INS: A DIFFERENT FINANCING PROBLEM

Partner buy-ins are structurally different from acquisitions. The practice itself is not changing hands — an incoming physician (often an associate becoming a partner, sometimes an outside recruit) is purchasing an ownership interest. The capital flows from the new partner into either the practice (for new equity issuance) or the existing partners (for partial redemption).

Typical buy-in financing structures:

Practice-guaranteed personal loan. The most common structure for buy-ins in the $250K to $1.5M range. A term loan to the incoming partner, with the practice often providing a limited guarantee or assignment of distributions.
Phased buy-in over 3 to 7 years. Many groups structure buy-ins as multi-year installments funded from the partner's distributions. Financing accelerates the schedule when the incoming partner prefers to lock in equity sooner.
Senior facility expansion. Where the buy-in funds existing-partner redemption, the practice itself may upsize its senior facility to fund the redemption rather than financing it through the incoming partner.

For larger buy-ins ($1M+), the financing structure typically blends incoming-partner capital with practice-level debt, depending on tax structure and partnership agreement provisions.

HOW DIFFERENT MEDICAL SPECIALTIES UNDERWRITE

Lenders do not treat all physician groups the same. Specialty matters — both for revenue predictability and for the saleability of the underlying business.

Strong financing profiles:

Multispecialty groups. Diversification across specialties smooths revenue and reduces concentration risk.
Cardiology, gastroenterology, orthopedics, ophthalmology, urology, dermatology. Procedure-heavy specialties with strong commercial and Medicare reimbursement. Many of these have ASC (ambulatory surgery center) extensions that add fee-for-service revenue streams.
Primary care, internal medicine, pediatrics. Stable patient panels and predictable visit volume; capitation and value-based-care arrangements add recurring revenue components.
Radiology, pathology, anesthesiology. Hospital-contract-based practices with strong, predictable revenue from large facility partners.

More cautious underwriting:

Concierge or boutique cash-pay practices. Strong margins but smaller addressable patient bases and limited collateral.
Heavily Medicaid-concentrated practices. Reimbursement risk and state-by-state payment variability require additional underwriting.
Solo-practitioner practices in transition. Limited going-concern value once the founding physician retires; financing usually structured around the transition rather than the standalone practice.

ENTERPRISE VALUE AND EBITDA NORMALIZATION

For acquisition financing, the single most important number is normalized EBITDA. Practice financial statements rarely show "true" EBITDA on a comparable-to-buyer basis. Common normalization adjustments:

Physician compensation. Selling physicians often run their compensation well above (or well below) post-close market rates. Replacement compensation needs to be substituted at fair market value.
Owner perks. Vehicle, travel, family wages, and other discretionary expenses are added back where appropriate.
One-time costs. Litigation, EHR conversions, prior-period regulatory fines, and other non-recurring items are added back.
Real estate rent. If the practice owns its building, in-house rent is normalized to a market lease rate. If rent is paid to a related party at above-market rates, the excess is added back.

The post-normalization EBITDA — sometimes called "lender-adjusted EBITDA" or "transaction EBITDA" — is the basis for senior debt sizing (3.0x to 4.0x range) and for stretch capital from a subordinated lender (additional 1.0x to 2.0x).

FREQUENTLY ASKED QUESTIONS

Can a multi-doctor practice finance an acquisition without bringing in outside equity?Often, yes. For acquisitions where the combined senior debt, subordinated capital, and seller note cover the purchase price, the acquiring practice's partners may not need to write equity checks at closing. This is common in deals where the acquirer's existing EBITDA already supports the combined debt structure. How is subordinated debt different from a senior loan?Subordinated debt sits behind the senior lender in priority of repayment and security. In exchange for accepting that subordinated position, the lender prices the capital at a higher rate (often a mix of cash interest, payment-in-kind interest, and warrants or success fees). The advantage is that it gives the borrower additional debt capacity beyond what a senior lender alone will provide. How long does an acquisition financing take to close?For a clean transaction with audited or reviewed financials, signed letter of intent, and cooperative seller, 60 to 90 days is typical. Longer timelines (120+ days) are common when payor credentialing, real estate, or regulatory approvals are involved. What do partner buy-ins typically cost the incoming partner?That depends on the practice's valuation, the partnership agreement's buy-in formula, and the percentage being acquired. Buy-ins of $250K to $1.5M are common for established practices with $2M+ EBITDA. Many practices structure the buy-in as a multi-year installment to make it more accessible to incoming partners. Do lenders require personal guarantees from all partners?On senior facilities, limited personal guarantees from the controlling partner(s) are common, often structured as a "good-boy" guarantee covering fraud or misrepresentation rather than full payment guarantees. On smaller facilities or buy-ins, full personal guarantees are more common. The specific structure varies by lender and transaction size. How does owned real estate factor into the deal?If the selling practice owns the office building, the real estate is typically separated from the practice transaction. The acquiring group may purchase the building outright (financed through a commercial mortgage), lease it from the selling physician(s), or roll it into the broader transaction. The financing structure flexes accordingly.

NEXT STEP: STRUCTURE YOUR ACQUISITION OR BUY-IN

If your multi-doctor practice is considering an acquisition, partner buy-in, or ownership transition, structuring the capital stack correctly at the front end is the difference between a clean closing and a stalled deal.

Noble Funding has provided over $1 billion in business financing since 2005 and works with multi-doctor practices on senior debt, subordinated debt, junior capital, and commercial mortgage financing for acquisitions and partner buy-ins.

Call 1-800-916-3196 for a confidential consultation. There is no cost and no obligation.

Contact Us